Skip to main content
Equibles

Aberdeen Group plc

Position in RPRX — Royalty Pharma plc

CIK 1716774 EDINBURGH, X0
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$32,419,728
+$4,897,134 QoQ
Shares Held
578,201
+0.8% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#83
of 646 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Aberdeen Group plc holds $1,997,986,618 across 85 Biotechnology names. RPRX ranks #19 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MANE
Veradermics, Inc
 1,096,642 $134,821,167
2 QURE
uniQure N.V.
 2,848,117 $131,184,269
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 210,601 $104,611,833
4 ARGX
Argenx SE
 83,822 $77,767,536
5 ABVX
Abivax S.A.
 522,025 $69,565,051
6 REGN
Regeneron Pharmaceuticals, Inc.
 101,566 $63,330,462
7 ORKA
Oruka Therapeutics, Inc.
 646,943 $61,569,565
8 INSM
INSMED Inc
 577,437 $61,566,331

All Filings in RPRX

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $32,419,728 578,201
2026-03-31 $27,522,594 573,746
2025-12-31 $25,557,113 661,416
2025-09-30 $19,870,576 563,225
2025-06-30 $8,241,717 228,746
2025-03-31 $6,657,460 213,860
2024-12-31 $2,287,404 89,667
2024-09-30 $2,952,117 104,352
2024-06-30 $31,327,795 1,188,009
2024-03-31 $39,432,407 1,298,400
2023-12-31 $35,319,465 1,257,368
2023-09-30 $100,571,855 3,705,669
2023-06-30 $119,122,202 3,875,153
2023-03-31 $143,342,291 3,978,415
2022-12-31 $139,010,688 3,517,477
2022-09-30 $137,981,011 3,434,072
2022-06-30 $149,952,221 3,566,894
2022-03-31 $87,236,502 2,239,130
2021-12-31 $91,093,073 2,285,899
2021-09-30 $65,093,378 1,801,145
2021-06-30 $77,225,608 1,884,011
2021-03-31 $1,248,535 28,623
2020-12-31 $510,660 10,203